Faes Farma (Spain) Top Management
FAE Stock | EUR 3.57 0.03 0.85% |
Faes Farma employs about 1.6 K people. The company is managed by 2 executives with a total tenure of roughly 22 years, averaging almost 11.0 years of service per executive, having 782.5 employees per reported executive. Evaluation of Faes Farma's management performance can provide insight into the firm performance.
Mariano Angulo Chairman Chairman of the Board |
Faes |
Faes Farma Management Team Effectiveness
The company has return on total asset (ROA) of 0.1039 % which means that it generated a profit of $0.1039 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1638 %, meaning that it generated $0.1638 on every $100 dollars invested by stockholders. Faes Farma's management efficiency ratios could be used to measure how well Faes Farma manages its routine affairs as well as how well it operates its assets and liabilities.Faes Farma Workforce Comparison
Faes Farma SA is one of the top stocks in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 20,178. Faes Farma holds roughly 1,565 in number of employees claiming about 8% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.19 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.22 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.22. Faes Farma SA Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Faes Farma SA Price Series Summation is a cross summation of Faes Farma price series and its benchmark/peer.
Faes Farma Notable Stakeholders
A Faes Farma stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Faes Farma often face trade-offs trying to please all of them. Faes Farma's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Faes Farma's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Mariano Angulo | Chairman of the Board | Profile | |
Gonzalo Iribarnegaray | Secretary, Director | Profile |
About Faes Farma Management Performance
The success or failure of an entity such as Faes Farma SA often depends on how effective the management is. Faes Farma management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Faes management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Faes management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Faes Farma, S.A., a pharmaceutical company, researches, develops, produces, and commercializes pharmaceutical products and raw materials. Faes Farma, S.A. was founded in 1933 and is headquartered in Madrid, Spain. FAES FARMA operates under Medical Instruments Supplies classification in Spain and is traded on Madrid SE C.A.T.S.. It employs 1264 people.
Please note, the presentation of Faes Farma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Faes Farma's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Faes Farma's management manipulating its earnings.
Faes Farma Workforce Analysis
Traditionally, organizations such as Faes Farma use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Faes Farma within its industry.Faes Farma Manpower Efficiency
Return on Faes Farma Manpower
Revenue Per Employee | 254.7K | |
Revenue Per Executive | 199.3M | |
Net Income Per Employee | 53.2K | |
Net Income Per Executive | 41.6M |
Complementary Tools for Faes Stock analysis
When running Faes Farma's price analysis, check to measure Faes Farma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Faes Farma is operating at the current time. Most of Faes Farma's value examination focuses on studying past and present price action to predict the probability of Faes Farma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Faes Farma's price. Additionally, you may evaluate how the addition of Faes Farma to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |